In aspirin-treated CABG patients, blood loss was 606 (237) mL with desmopressin versus 601 (301) mL with placebo (P = 0.93).
In plain wordsIn aspirin-treated CABG patients, desmopressin did not significantly change postoperative blood loss compared with placebo.
- Peptide
- Desmopressin
- Outcome
- No significant changePostoperative blood loss over 16 hours
- Study
n = 100
- Comparator
- Placebo
- Outcome group
- Bleeding · Cardiovascular
- Studied dose
- 0.3 micro g/kgAs given in this study (human).
Measurements
- Blood loss
- 606 mL
- desmopressin
- Blood loss SD
- 237 mL
- desmopressin
- Blood loss
- 601 mL
- placebo
- Blood loss SD
- 301 mL
- placebo
- P value
- 0.93
- between groups
- Difference confidence interval
- −107 to 117 mL
- 95% confidence interval
Source sentences
The mean (SD) bleeding was 606 (237) mL in the desmopressin group and 601 (301) mL in the placebo group (P = 0.93), representing no significant difference (95% confidence interval, -107 to 117 mL).
5 context sentences(design, population, supporting numbers)
Postoperative blood loss was recorded for 16 h.
We evaluated the effects of desmopressin on postoperative bleeding in CABG patients who were treated with aspirin 75 or 160 mg until the day before surgery.
The study was a prospective, randomized, double-blinded, placebo-controlled, parallel group trial.
One-hundred patients were included and divided into two groups.
One group received desmopressin 0.3 micro g/kg and the other received placebo (0.9% NaCl) after the neutralization of heparin with protamine sulfate.